ARCHIVES

Top Officials Resign From San Antonio’s Institute for Drug Development.

This article is from The Cancer Letter archive.

Vol. 33 No. 03 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

NIH Forming Special Emphasis Panel To Review Clinical Oncology Grants

September 18, 1998

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

NCI Gets Long List Of Consortium Center Needs, Including New Guidelines, Review, More “Glue”

September 14, 1984

In Brief: Comprehensive Centers “Jewel In Crown” Of Cancer Program, DeVita Says; Boutwell New NCAB Member

February 18, 1983